Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer’s
The findings demonstrate how the brain’s memory centre operates at a ‘watershed’ making it especially vulnerable to damage
Study suggests increasing blood flow in the hippocampus might be really effective at preventing...
Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment
By Rashed Karim
Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences
It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...
Build-up of brain proteins affects genes in Alzheimer’s disease
New research has shed fresh light on how the build-up of two proteins in the brain might affect the activity of genes involved in Alzheimer’s disease.
Researchers at the University of Exeter worked in collaboration...
Games and stimulation mitigate cognitive decline in older adults
Older people may be able to boost their working memory with a new approach that couples online therapeutic games with a non-invasive brain stimulation technique.
Working memory is critical for people to function well in...
NETPark: the hi-tech force for growth in County Durham
NETPark of Durham provides world-class laboratory, clean room and office space to science, technology and engineering companies, ranging from start-ups to global AIM-listed firms.
Managed by Business Durham and backed by on-site strategic partner CPI...
Euro biotech: breaking down the barriers to a golden age
Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality.
Europe’s tech sector is going from strength to strength....
90 years on, the time-bomb of antibiotic resistance
By Professor Colin Garner
The events of 28 September 1928 could justifiably lay claim to being called the most significant breakthrough in medical history.
With typical ingenuity and a quantity of genius, Sir Alexander Fleming discovered...
Over three million surgical operations and cancer treatments a year in England may become...
New data published by Public Health England (PHE) show that antibiotic resistant bloodstream infections continue to rise in England, with an estimated 35% increase from 2013 to 2017 (from 12,250 in 2013 to...
Diagnostic devices reimagined
Diagnostic devices are coming on in leaps and bounds but you may be surprised to learn that one device that’s remained much the same since the late 1950s is the colonoscope. One researcher working...
A global surveillance model is vital for future pandemic prevention
Broad viral surveillance is essential in pandemic prevention to allow for detection of potential threats and the immediate early launch of health protocols against pathogens. Yves Dubaquie, senior vice president of diagnostics, PerkinElmer, Inc.,...
NETPark – A Jewel in the region’s business crown
NETPark is a globally significant science park where innovation is the order of every day. It is where thinkers go to think, inventors go to invent, and doers go to do.
In the almost 20...
‘Super jelly’ can survive being run over by a car
Researchers have developed a jelly-like material that can withstand the equivalent of an elephant standing on it, and completely recover to its original shape, even though it’s 80 per cent water.
The soft-yet-strong material, developed...
A golden era for blood cancer treatments
It’s an exciting time in blood cancer research. As we deepen our understanding of the biology of blood cancer, researchers are developing better treatments than ever before, and we’re even beginning to talk about...
New materials could lead to implantable treatments for epilepsy
A prospective cure for one type of epilepsy could be one step closer, using flexible brain implants.
Bioengineering researchers from the University of Glasgow have investigated new...
Putting scientific research to better use
Plain-speaking research summaries could help the public make more informed decisions in major societal issues like COVID-19, says Charlie Rapple, co-founder of Kudos.
Misinformation about science and healthcare spreads quickly – and acting on the...
Oxford biotech firm secures £13.2m to develop world’s first treatment for rare, incurable and...
SynaptixBio, whose aim is to treat the genetic central nervous system disease TUBB4A-related leukodystrophy, has successfully raised £11.05m in its latest funding round to add to the £2.125m of seed funding from the last...